From: Place of birth and outcomes associated with large volume transfusion: an observational study
Risk factor | Booking | Birth | |
---|---|---|---|
RR(95% CI) | RR(95% CI) | ||
Maternal age | Under 20 | 1.3 (0.96,1.77) | 1.43 (1.05,1.93) |
20-34 | ref | ref | |
35+ | 1.56 (1.35,1.79) | 1.38 (1.2,1.59) | |
Maternal Country of birth | Australia/NZ | ref | ref |
Asia | 1.35 (1.15,1.59) | 1.39 (1.18,1.63) | |
Other | 0.94 (0.79,1.13) | 0.97 (0.81,1.16) | |
Multiple pregnancy | 2.21 (1.63,2.98) | 1.72 (1.25,2.36) | |
Morbid Obesity | 2.13 (1.15,3.93) | 1.54 (0.74,3.19) | |
Smoking during pregnancy | 1.37 (1.15,1.62) | 1.22 (1.02,1.45) | |
Chronic conditions | 3.51 (2.72,4.54) | 3.15 (2.43,4.09) | |
Assisted Reproductive technology | 2.04 (1.47,2.83) | 1.61 (1.18,2.2) | |
Previous PPH | 9.66 (8.5,10.97) | 8.36 (7.33,9.53) | |
Uterine surgery (5 years) | 2.24 (1.03,4.87) | 2.4 (1.14,5.01) | |
Uterine fibroids (1 year) | 3.12 (1.42,6.85) | 2.29 (1.06,4.98) | |
Parity | Primiparous | ref | ref |
Multiparous no previous CSa | 0.65 (0.56,0.75) | 0.71 (0.62,0.83) | |
Multiparous, previous CSa | 1.25 (1.05,1.49) | 1.29 (1.08,1.54) | |
Low socioeconomic status | 1.25 (1.09,1.44) | 1.25 (1.08,1.44) | |
Placenta Praevia | 9.27 (7.53,11.43) | ||
Pregnancy hypertension | 1.49 (1.23,1.79) | ||
Induction | 1.3 (1.13,1.49) | ||
Placental abruption | 7.01 (5.17,9.49) | ||
Gestation (weeks) | 20-32 | 1.65 (1.27,2.15) | |
33-36 | 1.47 (1.2,1.8) | ||
37+ | ref |